About
About us
Team
History
Science
Our pipeline
CSF1R
GPR17
News
Careers
Contact
Myrobalan News
ALL
News
Press Release
Filter by year
All
2024
2023
2022
2021
Press Release
Oct 31, 2024
Myrobalan Therapeutics Appoints Robin Kleiman Ph.D., as Chief Scientific Officer
Read more
Press Release
Oct 16, 2024
Myrobalan Therapeutics Strengthens Board of Directors with Appointment of Emma Reeve
Read more
Press Release
Sep 18, 2024
Myrobalan Presents GPR17 Antagonist Preclinical Data at ECTRIMS 2024
Read more
Press Release
Jul 29, 2024
Myrobalan Therapeutics Names Grant Bogle to Board of Directors
Read more
News
May 2, 2024
Co-Founder, Professor Guoping Feng (MIT/Broad) Inducted into the National Academy of Sciences
Read more
Press Release
Feb 7, 2024
Myrobalan Therapeutics Receives a Grant from the ALS Association to Advance its CSF1R Inhibitor Program
Read more
Press Release
Jan 10, 2024
Myrobalan Therapeutics Completes Series A Financing of $24 Million to Develop Potentially First-in-Class CNS Therapeutics with Restorative Potential
Read more
News
Oct 2, 2023
Co-Founder, Professor Guoping Feng (MIT/Broad) Inducted into the National Academy of Medicines
Read more
News
May 15, 2023
Myrobalan Wins First Place in International Biotech Start-up Pitch Competition
Read more
1
2